Pharmaceutical Business review

CMS announces initiation of cancer treatment with Monaco system

Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in Rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application.

Featuring biological modeling, constrained optimization, and Monte Carlo dose calculation algorithms, Monaco is said to represent a fundamentally new approach to intensity modulated radiotherapy treatment (IMRT) planning, including a unique and sophisticated set of tools to make the radiotherapy planning process easier, more straightforward and clinically reliable.

Moyed Miften, Allegheny General Hospital’s chief of medical physics, said: “The biologically-based Monaco IMRT treatment planning system produces clinically relevant plans, which are dosimetrically superior to plans from dose-based IMRT treatment planning systems, feature shorter plan delivery times, and can be easily verified with normal QA procedures.

“The multi-criteria optimization and the sensitivity analysis tools in the Monaco system also help reduce the time needed to optimize IMRT plans.”